BCR–ABL activity measured by 50% inhibitory concentration...

BCR–ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response

Simara, Pavel, Peterkova, Martina, Stejskal, Stanislav, Potesilova, Michaela, Koutna, Irena, Racil, Zdenek, Razga, Filip, Jurcek, Tomas, Dvorakova, Dana, Mayer, Jiri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
53
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2012.656104
Date:
August, 2012
File:
PDF, 191 KB
english, 2012
Conversion to is in progress
Conversion to is failed